Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies

OBJECTIVE: Opioid-induced constipation is among the most common side effects associated with opioid use in patients with chronic non-cancer pain, and it can have a significant negative impact on health-related quality of life (QOL). This analysis evaluated the effect of naldemedine 0.2 mg on patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Camilleri, Michael, Hale, Martin, Morlion, Bart, Tack, Jan, Webster, Lynn, Wild, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291809/
https://www.ncbi.nlm.nih.gov/pubmed/34295186
http://dx.doi.org/10.2147/JPR.S282738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291809/
https://www.ncbi.nlm.nih.gov/pubmed/34295186
http://dx.doi.org/10.2147/JPR.S282738

Ejemplares similares